Alpha 2.0
Login Register
» Authors » Marjorie Stiegler

Marjorie Stiegler

Explore the profile of Marjorie Stiegler including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 11
Citations 67
Followers 0
Related Specialties
Pulmonary Medicine
Anesthesiology
Biomedical Engineering
Top 10 Co-Authors
Michael Bogart
David Mannino
Fei Chen
Harendra Arora
Mark Small
David A Lipson
Benjamin Wu
Susan M Martinelli
James Siddall
Fernando J Martinez
Published In
Pulm Ther
J Educ Perioper Med
Int J Chron Obstruct Pulmon Dis
Simul Healthc
Respir Res
Affiliations
Soon will be listed here.
Recent Articles
1.
No Miracles in Two Minutes: A Randomized Controlled Study on the Impact of Preparatory Expansive Posing on Anesthesiology Residents' Performance in Mock Structured Oral Examinations
Chen F, Stiegler M, Martinelli S, Arora H, Isaak R
J Educ Perioper Med . 2023 Jun; 25(2):E700. PMID: 37377508
Background: The objective of this study was to evaluate the impact of engaging in preparatory expansive posing on the performance of anesthesiology trainees during a mock structured oral examination. Methods:...
2.
The Burden of Nocturnal Symptoms in Patients with Chronic Obstructive Pulmonary Disease: Results of a Real-World Survey in the USA
Soler X, Siddall J, Small M, Stiegler M, Bogart M
Pulm Ther . 2022 Jul; 8(3):269-282. PMID: 35877036
Introduction: Patients with chronic obstructive pulmonary disease (COPD) often have poor sleep quality and report a worsening of respiratory symptoms during night-time. However, current clinical guidelines for COPD management do...
3.
Patient and Clinical Demographics of New Users to Single-Inhaler Triple Therapy in Patients with Chronic Obstructive Pulmonary Disease
Wu B, Mannino D, Mu G, Stiegler M, Bogart M
Pulm Ther . 2022 Apr; 8(2):195-208. PMID: 35467260
Introduction: Single-inhaler fluticasone furoate/umeclidinium/vilanterol (FF/UMEC/VI) triple therapy was approved by the United States Food and Drug Administration in 2017 as a maintenance therapy for chronic obstructive pulmonary disease (COPD). Patient...
4.
Adherence and persistence to once-daily single-inhaler versus multiple-inhaler triple therapy among patients with chronic obstructive pulmonary disease in the USA: A real-world study
Mannino D, Bogart M, Wu B, Germain G, Laliberte F, MacKnight S, et al.
Respir Med . 2022 Apr; 197:106807. PMID: 35429764
Background: Triple therapy comprising an inhaled corticosteroid, long-acting muscarinic antagonist, and long-acting β agonist (ICS/LAMA/LABA) is recommended for chronic obstructive pulmonary disease (COPD) patients at risk of exacerbation. Multiple-inhaler triple...
5.
Treatment Patterns for Chronic Obstructive Pulmonary Disease (COPD) in the United States: Results from an Observational Cross-Sectional Physician and Patient Survey
Mannino D, Siddall J, Small M, Haq A, Stiegler M, Bogart M
Int J Chron Obstruct Pulmon Dis . 2022 Apr; 17:749-761. PMID: 35418752
Purpose: There is a high prevalence of chronic obstructive pulmonary disease (COPD) in the United States (US). Although guidelines are available for the treatment of COPD, evidence suggests that management...
6.
Evaluating Triple Therapy Treatment Pathways in Chronic Obstructive Pulmonary Disease (COPD): A Machine-Learning Predictive Model
Bogart M, Liu Y, Oakland T, Stiegler M
Int J Chron Obstruct Pulmon Dis . 2022 Apr; 17:735-747. PMID: 35418750
Purpose: Inhaled triple therapy (TT) comprising a long-acting muscarinic antagonist, long-acting β agonist, and inhaled corticosteroid is recommended for symptomatic chronic obstructive pulmonary disease (COPD) patients, or those at risk...
7.
Higher COPD Assessment Test Score Associated With Greater Exacerbations Risk: A Post Hoc Analysis of the IMPACT Trial
Thomashow B, Stiegler M, Criner G, Dransfield M, Halpin D, Han M, et al.
Chronic Obstr Pulm Dis . 2021 Dec; 9(1):68-79. PMID: 34972260
Background: In the InforMing the PAthway of COPD Treatment (IMPACT) trial, single-inhaler fluticasone furoate/umeclidinium/vilanterol (FF/UMEC/VI) reduced moderate/severe exacerbation rates versus FF/VI and UMEC/VI in patients with chronic obstructive pulmonary disease...
8.
Once-daily single-inhaler versus twice-daily multiple-inhaler triple therapy in patients with COPD: lung function and health status results from two replicate randomized controlled trials
Ferguson G, Brown N, Compton C, Corbridge T, Dorais K, Fogarty C, et al.
Respir Res . 2020 May; 21(1):131. PMID: 32471423
Background: The comparative efficacy of inhaled corticosteroid/long-acting muscarinic antagonist/long-acting β-agonist (ICS/LAMA/LABA) triple therapy administered via single or multiple inhalers in patients with chronic obstructive pulmonary disease (COPD) has not been...
9.
Replicating an Educational OSCE Project for Skill Assessment of Junior Anesthesiology Residents at Multiple Institutions: A Qualitative Description
Rebel A, DiLorenzo A, Isaak R, McGrane S, Moran K, Mobley E, et al.
J Educ Perioper Med . 2018 Jul; 20(2):E622. PMID: 30057933
Background: Educational research projects are often developed and implemented at a single institution. However, the research project methods and results may not be generalizable and able to be replicated successfully...
10.
Comparing Real-time Versus Delayed Video Assessments for Evaluating ACGME Sub-competency Milestones in Simulated Patient Care Environments
Isaak R, Stiegler M, Hobbs G, Martinelli S, Zvara D, Arora H, et al.
Cureus . 2018 May; 10(3):e2267. PMID: 29736352
Background Simulation is an effective method for creating objective summative assessments of resident trainees. Real-time assessment (RTA) in simulated patient care environments is logistically challenging, especially when evaluating a large...